5:55 PM
 | 
Jul 16, 2014
 |  BC Extra  |  Company News

Pfizer to acquire sterile injectable company InnoPharma

Pfizer Inc. (NYSE:PFE) will acquire InnoPharma Inc. (Piscataway, N.J.) for $225 million in cash up front. InnoPharma is also eligible for up to $135 million in milestones. InnoPharma develops sterile injectable formulations of...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >